Stratview Research has published a new report titled “Tissue Diagnostics Market” which is segmented by Product Type (Consumables [Antibodies, Kits, Reagents, and Probes] and Instruments [Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments]), by Technology Type (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, and Special Staining), by Disease Type (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Other Diseases), by End-User Type (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and  Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

As per the study, tissue Diagnostics Market is likely to witness a steady CAGR of 6.9%, during the forecast period owing to the high prevalence of cancer and chronic diseases, infrastructure development for cancer diagnosis, and increasing healthcare expenditure coupled with growing health awareness. In addition, technological advancements in the field of tissue diagnostics and aging population are further expected to bolster the growth of the market during the forecast period.

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis -

Based on the product type, the market is segmented as consumables and instruments. The consumables segment is expected to register a higher growth during the forecast period. The growth of the segment is attributed to the cost-effectiveness and ease of use of consumables. Furthermore, the growing number of reagent rental agreements is also one of the major factors driving the growth of the consumables market.

Based on the technology type, the market is segmented as immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. The immunohistochemistry segment is expected to lead the market over the forecast period. The increasing number of chronic diseases can be attributed to the segment's growth, where this technology is mostly used in tissue diagnostics.

Which Region is expected to remain the largest market?

In terms of regions, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the world. Among these regions, North America is expected to be dominant throughout the forecast period. The market growth in this region is majorly due to aging population, increasing number of cancer cases, and increasing healthcare expenditure. In addition, infrastructure development for hospitals and clinical laboratories is expected to drive the growth of the regional market during the forecast period. Europe and Asia-Pacific are also expected to offer substantial growth opportunities over the forecast period.

Who are the Key Players in the Market?

This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Tissue Diagnostics Market:

• Abbott Laboratories
• Abcam plc.
• Agilent Technologies, Inc.
• Cancer Genetics Inc.
• Cell Signaling Technology, Inc.
• Danaher Corporation
• Hoffmann-La Roche Ltd
• Merck KGaA
• Sakura Finetek Japan Co., Ltd.
• Thermo Fisher Scientific Inc.

Get a free sample- https://www.stratviewresearch.com/Request-Sample/406/tissue-diagnostics-market-tissue.html#form

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.